Cargando…

Correction to: Pirfenidone attenuates synovial fibrosis and postpones the progression of osteoarthritis by anti-fibrotic and anti-inflammatory properties in vivo and in vitro

Detalles Bibliográficos
Autores principales: Wei, Qilu, Kong, Ning, Liu, Xiaohui, Tian, Run, Jiao, Ming, Li, Yiyang, Guan, Huanshuai, Wang, Kunzheng, Yang, Pei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522190/
https://www.ncbi.nlm.nih.gov/pubmed/34663335
http://dx.doi.org/10.1186/s12967-021-03106-8
_version_ 1784585045526183936
author Wei, Qilu
Kong, Ning
Liu, Xiaohui
Tian, Run
Jiao, Ming
Li, Yiyang
Guan, Huanshuai
Wang, Kunzheng
Yang, Pei
author_facet Wei, Qilu
Kong, Ning
Liu, Xiaohui
Tian, Run
Jiao, Ming
Li, Yiyang
Guan, Huanshuai
Wang, Kunzheng
Yang, Pei
author_sort Wei, Qilu
collection PubMed
description
format Online
Article
Text
id pubmed-8522190
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85221902021-10-21 Correction to: Pirfenidone attenuates synovial fibrosis and postpones the progression of osteoarthritis by anti-fibrotic and anti-inflammatory properties in vivo and in vitro Wei, Qilu Kong, Ning Liu, Xiaohui Tian, Run Jiao, Ming Li, Yiyang Guan, Huanshuai Wang, Kunzheng Yang, Pei J Transl Med Correction BioMed Central 2021-10-18 /pmc/articles/PMC8522190/ /pubmed/34663335 http://dx.doi.org/10.1186/s12967-021-03106-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Wei, Qilu
Kong, Ning
Liu, Xiaohui
Tian, Run
Jiao, Ming
Li, Yiyang
Guan, Huanshuai
Wang, Kunzheng
Yang, Pei
Correction to: Pirfenidone attenuates synovial fibrosis and postpones the progression of osteoarthritis by anti-fibrotic and anti-inflammatory properties in vivo and in vitro
title Correction to: Pirfenidone attenuates synovial fibrosis and postpones the progression of osteoarthritis by anti-fibrotic and anti-inflammatory properties in vivo and in vitro
title_full Correction to: Pirfenidone attenuates synovial fibrosis and postpones the progression of osteoarthritis by anti-fibrotic and anti-inflammatory properties in vivo and in vitro
title_fullStr Correction to: Pirfenidone attenuates synovial fibrosis and postpones the progression of osteoarthritis by anti-fibrotic and anti-inflammatory properties in vivo and in vitro
title_full_unstemmed Correction to: Pirfenidone attenuates synovial fibrosis and postpones the progression of osteoarthritis by anti-fibrotic and anti-inflammatory properties in vivo and in vitro
title_short Correction to: Pirfenidone attenuates synovial fibrosis and postpones the progression of osteoarthritis by anti-fibrotic and anti-inflammatory properties in vivo and in vitro
title_sort correction to: pirfenidone attenuates synovial fibrosis and postpones the progression of osteoarthritis by anti-fibrotic and anti-inflammatory properties in vivo and in vitro
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522190/
https://www.ncbi.nlm.nih.gov/pubmed/34663335
http://dx.doi.org/10.1186/s12967-021-03106-8
work_keys_str_mv AT weiqilu correctiontopirfenidoneattenuatessynovialfibrosisandpostponestheprogressionofosteoarthritisbyantifibroticandantiinflammatorypropertiesinvivoandinvitro
AT kongning correctiontopirfenidoneattenuatessynovialfibrosisandpostponestheprogressionofosteoarthritisbyantifibroticandantiinflammatorypropertiesinvivoandinvitro
AT liuxiaohui correctiontopirfenidoneattenuatessynovialfibrosisandpostponestheprogressionofosteoarthritisbyantifibroticandantiinflammatorypropertiesinvivoandinvitro
AT tianrun correctiontopirfenidoneattenuatessynovialfibrosisandpostponestheprogressionofosteoarthritisbyantifibroticandantiinflammatorypropertiesinvivoandinvitro
AT jiaoming correctiontopirfenidoneattenuatessynovialfibrosisandpostponestheprogressionofosteoarthritisbyantifibroticandantiinflammatorypropertiesinvivoandinvitro
AT liyiyang correctiontopirfenidoneattenuatessynovialfibrosisandpostponestheprogressionofosteoarthritisbyantifibroticandantiinflammatorypropertiesinvivoandinvitro
AT guanhuanshuai correctiontopirfenidoneattenuatessynovialfibrosisandpostponestheprogressionofosteoarthritisbyantifibroticandantiinflammatorypropertiesinvivoandinvitro
AT wangkunzheng correctiontopirfenidoneattenuatessynovialfibrosisandpostponestheprogressionofosteoarthritisbyantifibroticandantiinflammatorypropertiesinvivoandinvitro
AT yangpei correctiontopirfenidoneattenuatessynovialfibrosisandpostponestheprogressionofosteoarthritisbyantifibroticandantiinflammatorypropertiesinvivoandinvitro